Patents by Inventor Shanping Wang

Shanping Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230103774
    Abstract: The invention discloses the medicinal use of kaurene compound in the prevention and treatment of sepsis, systemic inflammatory response syndrome (SIRS) and multiple organ failure caused by sepsis, including acute pulmonary failure, acute heart failure and renal failure.
    Type: Application
    Filed: April 12, 2021
    Publication date: April 6, 2023
    Inventors: Shanping Wang, Wen TAN
  • Patent number: 5910628
    Abstract: The present invention provides a method of increasing the production of a protein translated from an uncapped eukaryotic messenger ribonucleic acid (mRNA), comprising the steps of: selecting a nucleotide sequence encoding a protein to be expressed; joining nucleotides 1-168 of the barley yellow dwarf virus RNA, PAV serotype to the 5' untranslated region of said uncapped mRNA, said nucleotides 1-168 comprising the 5' untranslated region plus first 27 nucleotides of the open reading frame of the barley yellow dwarf virus RNA; linking nucleotides 4513-5677 of the barley yellow dwarf virus RNA, PAV serotype, to the 3' untranslated region of said uncapped mRNA; and expressing the protein.
    Type: Grant
    Filed: May 20, 1997
    Date of Patent: June 8, 1999
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: W. Allen Miller, Shanping Wang